IL149005A0 - Hexahydrofuro-2', 3-bifuran-3-yl-n-{3'(1, 3-benzodioxol-5-ylsulfonyl) (isobutyl) amino-1-benzyl-2-hydroxypropyl} carbamate as restroviral protease inhibitor - Google Patents

Hexahydrofuro-2', 3-bifuran-3-yl-n-{3'(1, 3-benzodioxol-5-ylsulfonyl) (isobutyl) amino-1-benzyl-2-hydroxypropyl} carbamate as restroviral protease inhibitor

Info

Publication number
IL149005A0
IL149005A0 IL14900500A IL14900500A IL149005A0 IL 149005 A0 IL149005 A0 IL 149005A0 IL 14900500 A IL14900500 A IL 14900500A IL 14900500 A IL14900500 A IL 14900500A IL 149005 A0 IL149005 A0 IL 149005A0
Authority
IL
Israel
Prior art keywords
restroviral
bifuran
hexahydrofuro
ylsulfonyl
benzodioxol
Prior art date
Application number
IL14900500A
Other languages
English (en)
Original Assignee
Us Gov Health & Human Serv
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv, Tibotec Pharm Ltd filed Critical Us Gov Health & Human Serv
Publication of IL149005A0 publication Critical patent/IL149005A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL14900500A 1999-10-06 2000-10-06 Hexahydrofuro-2', 3-bifuran-3-yl-n-{3'(1, 3-benzodioxol-5-ylsulfonyl) (isobutyl) amino-1-benzyl-2-hydroxypropyl} carbamate as restroviral protease inhibitor IL149005A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15785099P 1999-10-06 1999-10-06
PCT/EP2000/009917 WO2001025240A1 (en) 1999-10-06 2000-10-06 HEXAHYDROFURO'2,3-B!FURAN-3-YL-N- {3'(1,3-BENZODIOXOL -5- YLSULFONYL) (ISOBUTYL) AMINO! -1-BENZYL-2-HYDROXYPROPYL} CARBAMATE AS RETROVIRAL PROTEASE INHIBITOR

Publications (1)

Publication Number Publication Date
IL149005A0 true IL149005A0 (en) 2002-11-10

Family

ID=22565540

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14900500A IL149005A0 (en) 1999-10-06 2000-10-06 Hexahydrofuro-2', 3-bifuran-3-yl-n-{3'(1, 3-benzodioxol-5-ylsulfonyl) (isobutyl) amino-1-benzyl-2-hydroxypropyl} carbamate as restroviral protease inhibitor
IL149005A IL149005A (en) 1999-10-06 2002-04-04 Hexhydropuro - [2,3-b] Furan-3-Il N - {[(1,3-Benzodioxole-5-Isulfonyl) (isobutyl) amino] - 1-Benzyl-2-Hydroxypropyl} Carbamate used as a retroviral protease inhibitor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149005A IL149005A (en) 1999-10-06 2002-04-04 Hexhydropuro - [2,3-b] Furan-3-Il N - {[(1,3-Benzodioxole-5-Isulfonyl) (isobutyl) amino] - 1-Benzyl-2-Hydroxypropyl} Carbamate used as a retroviral protease inhibitor

Country Status (25)

Country Link
US (2) US6649651B1 (cs)
EP (1) EP1222192B8 (cs)
JP (1) JP4951179B2 (cs)
KR (1) KR100792391B1 (cs)
CN (1) CN1191256C (cs)
AP (1) AP1459A (cs)
AT (1) ATE398623T1 (cs)
AU (1) AU781656B2 (cs)
BR (1) BR0014602A (cs)
CA (1) CA2386850C (cs)
CZ (1) CZ300031B6 (cs)
DE (1) DE60039244D1 (cs)
DK (1) DK1222192T3 (cs)
ES (1) ES2307533T3 (cs)
HU (1) HU228938B1 (cs)
IL (2) IL149005A0 (cs)
MX (1) MXPA02003607A (cs)
NO (1) NO327996B1 (cs)
NZ (1) NZ518580A (cs)
OA (1) OA12053A (cs)
PL (1) PL204924B1 (cs)
RU (1) RU2247123C2 (cs)
SK (1) SK287153B6 (cs)
WO (1) WO2001025240A1 (cs)
ZA (1) ZA200202655B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE398623T1 (de) * 1999-10-06 2008-07-15 Tibotec Pharm Ltd Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer
US7244752B2 (en) 2001-04-09 2007-07-17 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
ATE453648T1 (de) * 2001-09-10 2010-01-15 Tibotec Pharm Ltd Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
EP1472536A4 (en) * 2002-01-07 2007-02-14 Sequoia Pharmaceuticals VERSATILE INHIBITORS
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
HRP20050607B1 (hr) 2002-05-17 2014-07-04 Tibotec Pharmaceuticals Ltd. Supstituirani benzizoksazol sulfonamid hiv proteazni inhibitori širokog spektra
CN101445493A (zh) * 2002-08-02 2009-06-03 泰博特克药品有限公司 广谱2-氨基-苯并噻唑磺酰胺类hiv蛋白酶抑制剂
AU2003275675A1 (en) 2002-12-27 2004-07-29 Sumitomo Chemical Company, Limited Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same
MXPA06010365A (es) 2004-03-11 2007-05-04 Sequoia Pharmaceuticals Inc Inhibidores de proteasa retrovirales repelentes a la resistencia.
TWI383975B (zh) 2004-03-31 2013-02-01 Tibotec Pharm Ltd 製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法
KR100698291B1 (ko) * 2004-12-29 2007-03-22 엘지전자 주식회사 조명계
MX2007010378A (es) 2005-02-25 2007-09-25 Tibotec Pharm Ltd Sintesis del precursor inhibidor de la proteasa.
FR2888849B1 (fr) * 2005-07-19 2007-10-05 Pierre Fabre Medicament Sa Procede de preparation de la 4b-amino-4'-demethyl-4-desoxypodophyllotoxine
AR061838A1 (es) 2006-07-07 2008-09-24 Gilead Sciences Inc Moduladores de propiedades farmacocineticas de terapeuticos
AU2007277253A1 (en) * 2006-07-24 2008-01-31 Gilead Sciences, Inc. Bisfuranyl protease inhibitors
US8153829B2 (en) 2006-11-09 2012-04-10 Janssen Pharmaceutica N.V. Methods for the preparation of hexahydrofuro[2,3-B]furan-3-ol
EP2491785A1 (en) * 2006-11-21 2012-08-29 Purdue Research Foundation Method and compositions for treating HIV infections
EP3689353A1 (en) 2007-02-23 2020-08-05 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
EP2134336B1 (en) 2007-03-16 2013-12-11 Sequoia Pharmaceuticals Benzofuran-derived hiv protease inhibitors
ES2438275T3 (es) 2007-07-06 2014-01-16 Gilead Sciences, Inc. Moduladores de propiedades farmacocinéticas de agentes terapéuticos
US8759379B2 (en) 2008-01-04 2014-06-24 Gilead Sciences, Inc. Inhibitors of cytochrome P450
EP2244571A4 (en) 2008-01-17 2014-02-19 Purdue Research Foundation SMALL MOLECULAR INHIBITORS OF HIV PROTEASES
EP2307345A4 (en) 2008-07-01 2012-05-02 Purdue Research Foundation NON-PEPTIDINHIBITORS OF HIV-1 PROTEASE
WO2010006050A1 (en) 2008-07-09 2010-01-14 Purdue Research Foundation Hiv protease inhibitors and methods for using
RU2593790C2 (ru) 2009-12-21 2016-08-10 Янссен Сайенсиз Айрлэнд Юси Разлагаемый удаляемый имплантат для непрерывного высвобождения активного соединения
US8841467B2 (en) 2010-11-23 2014-09-23 Mylan Laboratories Limited Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol
JPWO2014024898A1 (ja) 2012-08-09 2016-07-25 住友化学株式会社 ヘキサヒドロフロフラノール誘導体の製造方法
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE154800T1 (de) * 1992-08-25 1997-07-15 Searle & Co N-(alkanoylamino-2-hydroxypropyl)-sulfonamide verwendbar als retrovirale proteaseninhibitoren
WO1994004492A1 (en) * 1992-08-25 1994-03-03 G.D. Searle & Co. Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
AU7669794A (en) * 1993-08-24 1995-03-21 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
AU4828199A (en) * 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
PT2336134T (pt) * 1998-06-23 2016-10-19 The Board Of Trustees Of The Univ Of Illionis Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia
GB9815567D0 (en) * 1998-07-18 1998-09-16 Glaxo Group Ltd Antiviral compound
ATE398623T1 (de) * 1999-10-06 2008-07-15 Tibotec Pharm Ltd Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer

Also Published As

Publication number Publication date
CA2386850C (en) 2010-03-30
EP1222192A1 (en) 2002-07-17
HUP0203130A2 (hu) 2003-01-28
AU7663800A (en) 2001-05-10
AP2002002472A0 (en) 2002-06-30
SK5702002A3 (en) 2003-01-09
PL354351A1 (en) 2004-01-12
SK287153B6 (sk) 2010-01-07
EP1222192B1 (en) 2008-06-18
EP1222192B8 (en) 2008-10-01
NZ518580A (en) 2004-01-30
US20050261364A1 (en) 2005-11-24
AU781656B2 (en) 2005-06-02
AP1459A (en) 2005-08-22
KR100792391B1 (ko) 2008-01-08
CN1191256C (zh) 2005-03-02
NO20021598D0 (no) 2002-04-04
IL149005A (en) 2006-12-31
HK1054746A1 (en) 2003-12-12
NO20021598L (no) 2002-05-29
OA12053A (en) 2006-05-02
DE60039244D1 (de) 2008-07-31
CZ20021419A3 (cs) 2002-10-16
ZA200202655B (en) 2003-09-23
US6649651B1 (en) 2003-11-18
NO327996B1 (no) 2009-11-02
ATE398623T1 (de) 2008-07-15
CZ300031B6 (cs) 2009-01-14
DK1222192T3 (da) 2008-10-20
BR0014602A (pt) 2002-06-11
RU2247123C2 (ru) 2005-02-27
HUP0203130A3 (en) 2005-01-28
ES2307533T3 (es) 2008-12-01
WO2001025240A1 (en) 2001-04-12
HU228938B1 (hu) 2013-06-28
PL204924B1 (pl) 2010-02-26
KR20020067503A (ko) 2002-08-22
JP2003511383A (ja) 2003-03-25
CN1407987A (zh) 2003-04-02
CA2386850A1 (en) 2001-04-12
JP4951179B2 (ja) 2012-06-13
US7157495B2 (en) 2007-01-02
MXPA02003607A (es) 2003-07-28

Similar Documents

Publication Publication Date Title
IL149005A0 (en) Hexahydrofuro-2', 3-bifuran-3-yl-n-{3'(1, 3-benzodioxol-5-ylsulfonyl) (isobutyl) amino-1-benzyl-2-hydroxypropyl} carbamate as restroviral protease inhibitor
ZA200204283B (en) Novel antidiabetic agents.
HUP0202812A3 (en) Novel bicyclonucleoside analogues
MXPA02005792A (es) 1-(aminofenil)-2-pirrolidonas como inhibidores de la integrina.
IL160081A0 (en) Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
MXPA01013406A (es) Compuestos inhibidores de vla-4.
ZA992447B (en) Quinoxalinones as serine protease inhibitors.
IL164608A0 (en) 2-(2,6-Dichlorophenyl)-diarylimidazoles
ZA992448B (en) Quinoxalinones as serine protease inhibitors.
PL334184A1 (en) Fungicidal compositions based on methyl n-(phenylacetyl)-n-(2,6-xylyl) alaninate
GB0014805D0 (en) Glassbreaker (2)
EP1179052A4 (en) SERINE PROTEASES
IL154675A0 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
PL376926A1 (pl) Nowe analogi 2',5'-oligoadenylanowe
AU3006800A (en) Efficient carbamate synthesis
ZA200202765B (en) Grinding head.
IL144540A0 (en) Carbamate derivatives of diaryl 1,3,4,-oxadiazolone
GB2347250B (en) Card-reading
EP1206233A4 (en) Serine proteases
HUP0203248A3 (en) Substituted ureas
ZA200109203B (en) VLA-4 inhibitor compounds.
EG23327A (en) Metraplant "iucd".
GB9904295D0 (en) Uses for worn out-tyres
ZA9811472B (en) Novel amines as pharmaceutical agents.
ZA987969B (en) Compounds useful as novel antiatherosclerotic agents.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed